Literature DB >> 22539522

Development of a siRNA and shRNA screening system based on a kinase fusion protein.

Sofie Pieraets1, Luk Cox, Olga Gielen, Jan Cools.   

Abstract

RNA interference (RNAi) is one of the processes in the cell that regulates mRNA expression levels. RNAi can be exploited to experimentally knockdown the expression of one or more genes in cell lines or even in cells in vivo and also became an interesting tool to develop new therapeutic approaches. One of the major challenges of using RNAi is selecting effective shRNAs or siRNAs that sufficiently down-regulate the expression of the target gene. Here, we describe a system to select functional shRNAs or siRNAs that makes use of the leukemia cell line Ba/F3 that is dependent on the expression of a mutant form of the PDGFRα kinase for its proliferation and survival. The basis of this system is the generation of an expression construct, where part of the open reading frame of the gene of interest is linked to the mutant PDGFRα. Thus, shRNAs or siRNAs that effectively target the gene of interest also result in a reduction of the expression of the mutant PDGFRα protein, which can be detected by a reduction of the proliferation of the cells. We demonstrate that this validation system can be used for the selection of effective siRNAs as well as shRNAs. Unlike other systems, the system described here is not dependent on obtaining high-transduction efficiencies, and nonspecific effects of the siRNAs or shRNAs can be detected by comparing the effects in the presence or absence of the growth factor interleukin-3.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22539522      PMCID: PMC3358651          DOI: 10.1261/rna.030015.111

Source DB:  PubMed          Journal:  RNA        ISSN: 1355-8382            Impact factor:   4.942


  28 in total

1.  High-throughput selection of effective RNAi probes for gene silencing.

Authors:  Rajeev Kumar; Douglas S Conklin; Vivek Mittal
Journal:  Genome Res       Date:  2003-10       Impact factor: 9.043

2.  Rational siRNA design for RNA interference.

Authors:  Angela Reynolds; Devin Leake; Queta Boese; Stephen Scaringe; William S Marshall; Anastasia Khvorova
Journal:  Nat Biotechnol       Date:  2004-02-01       Impact factor: 54.908

3.  High-throughput screening of effective siRNAs from RNAi libraries delivered via bacterial invasion.

Authors:  Hui-Fen Zhao; Denis L'Abbé; Normand Jolicoeur; Meiqun Wu; Zhen Li; Zhenbao Yu; Shi-Hsiang Shen
Journal:  Nat Methods       Date:  2005-11-18       Impact factor: 28.547

4.  Design of a genome-wide siRNA library using an artificial neural network.

Authors:  Dieter Huesken; Joerg Lange; Craig Mickanin; Jan Weiler; Fred Asselbergs; Justin Warner; Brian Meloon; Sharon Engel; Avi Rosenberg; Dalia Cohen; Mark Labow; Mischa Reinhardt; François Natt; Jonathan Hall
Journal:  Nat Biotechnol       Date:  2005-07-17       Impact factor: 54.908

5.  Fusion of EML1 to ABL1 in T-cell acute lymphoblastic leukemia with cryptic t(9;14)(q34;q32).

Authors:  Kim De Keersmaecker; Carlos Graux; Maria D Odero; Nicole Mentens; Riet Somers; Johan Maertens; Iwona Wlodarska; Peter Vandenberghe; Anne Hagemeijer; Peter Marynen; Jan Cools
Journal:  Blood       Date:  2005-02-15       Impact factor: 22.113

6.  Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells.

Authors:  S M Elbashir; J Harborth; W Lendeckel; A Yalcin; K Weber; T Tuschl
Journal:  Nature       Date:  2001-05-24       Impact factor: 49.962

7.  MOHITO, a novel mouse cytokine-dependent T-cell line, enables studies of oncogenic signaling in the T-cell context.

Authors:  Maria Kleppe; Nicole Mentens; Thomas Tousseyn; Iwona Wlodarska; Jan Cools
Journal:  Haematologica       Date:  2010-12-29       Impact factor: 9.941

8.  A tyrosine kinase created by fusion of the PDGFRA and FIP1L1 genes as a therapeutic target of imatinib in idiopathic hypereosinophilic syndrome.

Authors:  Jan Cools; Daniel J DeAngelo; Jason Gotlib; Elizabeth H Stover; Robert D Legare; Jorges Cortes; Jeffrey Kutok; Jennifer Clark; Ilene Galinsky; James D Griffin; Nicholas C P Cross; Ayalew Tefferi; James Malone; Rafeul Alam; Stanley L Schrier; Janet Schmid; Michal Rose; Peter Vandenberghe; Gregor Verhoef; Marc Boogaerts; Iwona Wlodarska; Hagop Kantarjian; Peter Marynen; Steven E Coutre; Richard Stone; D Gary Gilliland
Journal:  N Engl J Med       Date:  2003-03-27       Impact factor: 91.245

9.  PKC412 overcomes resistance to imatinib in a murine model of FIP1L1-PDGFRα-induced myeloproliferative disease.

Authors:  Jan Cools; Elizabeth H Stover; Christina L Boulton; Jason Gotlib; Robert D Legare; Sonia M Amaral; David P Curley; Nicole Duclos; Rebecca Rowan; Jeffery L Kutok; Benjamin H Lee; Ifor R Williams; Steven E Coutre; Richard M Stone; Daniel J DeAngelo; Peter Marynen; Paul W Manley; Thomas Meyer; Doriano Fabbro; Donna Neuberg; Ellen Weisberg; James D Griffin; D Gary Gilliland
Journal:  Cancer Cell       Date:  2003-05       Impact factor: 31.743

10.  Interference of hepatitis C virus RNA replication by short interfering RNAs.

Authors:  Sharookh B Kapadia; Amy Brideau-Andersen; Francis V Chisari
Journal:  Proc Natl Acad Sci U S A       Date:  2003-02-03       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.